2,500
Participants
Start Date
August 15, 2019
Primary Completion Date
March 31, 2038
Study Completion Date
March 31, 2038
Isoniazid/Rifapentine daily (4 weeks) plus pyridoxine (vitamin B6)
Isoniazid/Rifapentine daily (4 weeks) plus pyridoxine (vitamin B6)
Isoniazid/Rifapentine 12-weekly plus pyridoxine (vitamin B6)
Isoniazid/Rifapentine 12-weekly plus pyridoxine (vitamin B6)
Klang Hospital, Bangkok
Bhumibol Adulyadej Hospital, Bangkok
HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok
King Chulalongkorn Memorial Hospital, Bangkok
Police General Hospital, Bangkok
Taksin Hospital, Bangkok
the Public Health Centre 28 Krung thon buri, Bangkok
Pranangklao Hospital, Nonthaburi
Queen Savang Vadhana Memorial Hospital, Chon Buri
Maharat Nakhon Ratchasima Hospital, Nakhon Ratchasima
Sisaket Hospital, Si Sa Ket
Srinagarind Hospital, Khon Kaen
Sanpatong Hospital, Chiang Mai
Chiangrai Prachanukroh Hospital, Chiang Rai
Buddhachinnaraj Hospital, Phitsanulok
Hatyai Hospital, Songkhla
King Chulalongkorn Memorial Hospital
OTHER
Police General Hospital
OTHER
Pranangklao Hospital
UNKNOWN
Taksin Hospital
UNKNOWN
Bhumibol Adulyadej Hospital
OTHER
Klang Hospital
UNKNOWN
Chiang Rai Prachanukroh Hospital
UNKNOWN
Sanpatong Hospital
UNKNOWN
Queen Sawang Vadhana Memorial Hospital
UNKNOWN
Buddhachinnaraj Hospital
UNKNOWN
Maharat Nakhon Ratchasima Hospital
OTHER
HatYai Hospital
OTHER
Srinagarind Hospital, Khon Kaen University
OTHER
Sisaket Hospital
UNKNOWN
The Public Health Centre 28 Krung thon buri
UNKNOWN
The HIV Netherlands Australia Thailand Research Collaboration
OTHER